Epstein Secrets

3 101/27/2016 THYROXINE, FREE(FT4) TNP 0.80-1.73 ng/dL Test Not Performed: Specimen rejected for testing dut to moderate or marked heaolysis. FREE T4 INDEX TNP 1.5-3.8 T3(THYRONINE), TOTAL TNP 72-180 ng/dL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

12.9 ug/dL 7.5 10/27/2015 T3 UPTAKE (T3U) 29.3 24.3-39.0 X 29.1 10/27/2015 THYROXINE, FREE (FT4) 0.93 0.80-1.73 ng/dL 1.06 10/27/2015 FREE T4 INDEX 1.8 1.5-3.8 2.2 10 27 2015 T3 (THYRONINE), TOTAL 127 72-180 ng/dL 129 10/27/2015 PSA Total 0.70 <4.00 ng/mL 0.87 10/27/2015 NO

the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE 0.33 Not Estab. ng/mL I 0.31 10/27/201S BioReference Laboratories, Inc. Elmwood Park, NJ 07407 James Weisberger M.D. Page 3 of S Laboratory Director Prin

OXINE, FREE(FT4) TNP Test Not Performed: Specimen rejected for testing due hemolysis. 0.80-1.73 ng/dL to moderate or marked 0.93 101/27/2016 FREE T4 INDEX TNP 1.5-3.8 1.8 01/27/2016 T3(THYRONINE), TOTAL TNP Test Not Performed: Specimen rejected for testing due hemolysis. 72-180 ng/dl. t

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

OXINE, FREE(FT4) TNP lest Not Performed: Specimen rejected for testing due hemolysis. 0.80-1.73 ng/dL to moderate or marked 0.93 101/27/2016 FREE T4 INDEX TNP 1.5-3.8 1.8 01/27/2016 113(THYRONINE), TOTAL TNP Test Not Performed: Specimen rejected for testing due hemolysis. 72-180 ng/dL t

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate